Exact Sciences
EXAS
#1765
Rank
$9.52 B
Marketcap
$51.48
Share price
-3.29%
Change (1 day)
-13.86%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of June 2024 : $6.67 Billion USD

According to Exact Sciences's latest financial reports the company's total assets are $6.67 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31$6.47 B3.93%
2022-12-31$6.22 B-6.85%
2021-12-31$6.68 B35.73%
2020-12-31$4.92 B40.49%
2019-12-31$3.50 B130.03%
2018-12-31$1.52 B154.61%
2017-12-31$0.59 B58.75%
2016-12-31$0.37 B3.57%
2015-12-31$0.36 B16.37%
2014-12-31$0.31 B113.35%
2013-12-31$0.14 B30.78%
2012-12-31$0.11 B15.64%
2011-12-31$96.95 M0.45%
2010-12-31$96.51 M274.52%
2009-12-31$25.77 M336.93%
2008-12-31$5.89 M-59.59%
2007-12-31$14.59 M-38.85%
2006-12-31$23.86 M-36.93%
2005-12-31$37.84 M-32.55%
2004-12-31$56.11 M61.79%
2003-12-31$34.68 M-30.76%
2002-12-31$50.08 M-20.62%
2001-12-31$63.1 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
$1.08 B-83.74%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$1.23 B-81.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.1 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$139.09 B 1,984.35%๐Ÿ‡ซ๐Ÿ‡ท France